Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells

BACKGROUND AND AIM: We have previously identified ubiquitinated proteins (UPs) from tumor cell lysates as a promising vaccine for cancer immunotherapy in different mouse tumor models. In this study, we aimed at developing a highly efficient therapeutic adjuvant built-in nanovaccine (α-Al(2)O(3)-UPs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fang, Zhao, Jinjin, Wei, Yiting, Wen, Zhifa, Zhang, Yue, Wang, Xuru, Shen, Yanfei, Wang, Li-xin, Pan, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025662/
https://www.ncbi.nlm.nih.gov/pubmed/32103954
http://dx.doi.org/10.2147/IJN.S237578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025662/
https://www.ncbi.nlm.nih.gov/pubmed/32103954
http://dx.doi.org/10.2147/IJN.S237578

Ejemplares similares